XOMA Royalty (XOMA) Capital Expenditures Growth (3y) (2013 - 2017)
XOMA Royalty (XOMA) Capital Expenditures Growth (3y) (2013 - 2017) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -12.25% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -29.33% |
| Dec 31, 2016 | -34.58% |
| Mar 31, 2016 | -60.37% |
| Dec 31, 2015 | -27.80% |
| Sep 30, 2015 | -60.53% |
| Jun 30, 2015 | -31.90% |
| Mar 31, 2015 | -25.68% |
| Dec 31, 2014 | -48.51% |
| Sep 30, 2014 | -23.86% |
| Jun 30, 2014 | -71.68% |
| Mar 31, 2014 | -61.93% |
| Dec 31, 2013 | 17.27% |
| Sep 30, 2013 | 109.01% |